-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
tevogen
-
Tevogen Bio to investigate T cell therapy in long Covid
Tevogen Bio is set to study the potential therapeutic use of its investigational Covid-19 T cell therapy, TVGN-489, in long Covid. The finding that none of the patients in the TVGN 489 proof-of-concept (POC) trial, treated for their initial Covid infection, developed long Covid to date is...- John Mac
- Thread
- long covid t cells tevogen tvgn-489
- Replies: 1
- Forum: Long Covid news